Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis

Nitric Oxide - Biology and Chemistry

Volumn 7, Issue 4, 2002, Pages 277-282

  Failli, Paola ^a   Palmieri, Loredana ^a   D'Alfonso, Caterina ^a   Giovannelli, Lisa ^a   Generini, Sergio ^a   Rosso, Angela Del ^a   Pignone, Alberto ^a   Stanflin, Nirvana ^b   Orsi, Stefano ^b   Zilletti, Lucilla ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Alveolar macrophages; Inducible nitric oxide synthase; N acetylcysteine; Peroxynitrite; Superoxide anion; Systemic sclerosis

Indexed keywords

ACETYLCYSTEINE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; SUPEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN; PEROXYNITROUS ACID;

ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ASSAY; FLUOROMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; SYMPTOM; SYNTHESIS; SYSTEMIC SCLEROSIS; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ACETYLCYSTEINE; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEROXYNITROUS ACID; SCLERODERMA, SYSTEMIC; SUPEROXIDES;

EID: 18744410920     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00120-9     Document Type: Article

References (32)

1. I. Fajac, A. Kahan, C.J. Menkes, J.F. Dessanges, J. Dall'Ava-Santucci, A.T. Dinh-Xuan, Increased nitric oxide in exhaled air in patients with systemic sclerosis, Clin. Exp. Rheumatol. 16 (1998) 547-552.
2. S.A. Kharitonov, J.B. Cailes, C.M. Black, R.M. du Bois, P.J. Barnes, Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension, Thorax 52 (1997) 1051-1055.
3. G. Rolla, P. Colagrande, L. Brussino, C. Bucca, M.T. Bertero, F. Caligaris-Cappio, Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension, Lancet 351 (1998) 1491-1492.
4. T. Yamamoto, I. Katayama, K. Nishioka, Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis, J. Rheumatol. 25 (1998) 314-317.
5. T. Yamamoto, Y. Sawada, I. Katayama, K. Nishioka, Increased production of nitric oxide stimulated by interleukin-1 β in peripheral blood mononuclear cells in patients with systemic sclerosis, Br. J. Rheumatol. 37 (1998) 1123-1125.
6. S. Nicholson, M.G. Bonencini-Almeida, J.R. Lepa, J.R. Silva, C. Nathan, Q.W. Xie, R. Mumford, J.R. Weidner, J. Calaycay, J. Geng, N. Beochat, C. Linhares, W. Rom, J.L. Ho, Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis, J. Exp. Med. 183 (1996) 2293-2302.
7. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshall, B.A. Freeman, Apparent hydroxyl radical production by peroxynitrite. Implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. USA 87 (1990) 1620-1624.
8. J.P. Eiserich, M. Hristova, C.E. Cross, A.D. Jones, B.A. Freeman, B. Halliwel, A. van der Vliet, Formation of nitric oxide-derived inflammatory oxidants by myeloperixadase in neutrophils, Nature 391 (1998) 392-397.
9. P.J. Barnes, Nitric oxide, in: P.J. Barnes, I.W. Rodger, N.C. Thomson (Eds.), Asthma: Basic Mechanisms and Clinical Management, third ed., Academic Press, London, 1998, pp. 369-388.
10. D.F. Murrell, A radical proposal for the pathogenesis of scleroderma, J. Am. Acad. Dermatol. 28 (1993) 78-85.
11. G. Simonini, M. Matucci-Cerinic, S. Generini, M. Zoppi, M. Anichini, A. Cesaretti, A. Pignone, F. Falcini, T. Lotti, M. Cagnoni, Oxidative stress in systemic sclerosis, Mol. Cell. Biochem. 196 (1999) 85-91.
12. A.L. Herrick, K.J. Illingworth, J. Hollis, J.M. Gomez-Zumaquero, F.J. Tinahones, Antibodies against oxidized low density lipoproteins in systemic sclerosis, Rheumatology 40 (2001) 401-405.
13. P. Sambo, L. Jannino, M. Candela, A. Salvi, M. Donini, Dusi, M.M. Luchetti, A. Gabrielli, Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anions, J. Invest. Dermatol. 112 (1999) 78-84.
14. G. Cavallo, L. Sabadini, L. Rollo, M. Catenaccio, S. Lorenzini, N. Pipitone, R. Marcolongo, Nitric oxide synthesis in peripheral blood monocytes and polymorphonuclear cells from patients with systemic sclerosis, Rheumatology 38 (1999) 1301-1304.
15. P. Narula, J. Xu, J.A. Kazzaz, C.G. Robbins, J.M. Davies, S. Horowitz, Synergistic cytotoxicity from nitric oxide and hyperoxia in cultured lung cells, Am. J. Physiol. 274 (1998) L411-L416.
16. D. Saleh, P.J. Barnes, A. Giaid, Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis, Am. J. Respir. Crit. Care Med. 55(1997) 1763-1769.
17. G. Simonini, A. Pignone, S. Generini, F. Falcini, M. Matucci-Cerinic, Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis, Toxicology 155 (2000) 1-15.
18. C. Ceconi, S. Curello, A. Cargnoni, R. Ferrari, A. Albertini, O. Visioli, The role of glutathione status in the protection against ischaemic and reperfusion damage: Effects of N-acetylcysteine, J. Mol. Cell Cardiol. 20 (1988) 5-13.
19. S. Hashimoto, Y. Gon, K. Matsumoto, I. Takeshita, T. Horie, N-acetylcysteine attenuates TNF-α-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells, Br. J. Pharmacol. 132 (2001) 270-276.
20. A. Gillissen, D. Nowak, Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy, Respir. Med. 92 (1998) 609-623.
21. R. Pela, A.M. Calcagni, S. Subiaco, P. Isidori, A. Tubali, C.M. Sanguinetti, N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD, Respiration 66 (1999) 495-500.
22. P. Sambo, D. Amico, R. Giacomelli, M. Matucci-Cerinic, F. Salsano, G. Valentini, A. Gabrielli, Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: A pilot study, J. Rheumatol. 28 (2001) 2257-2262.
23. E. Drost, S. Lannan, M.M.E. Bridgerman, D. Brown, C. Selby, K. Donaldson, W. MacNee, Lack of effect of N-acetylcysteine on the release of oxygen radicals from neutrophils and alveolar macrophages, Eur. J. Resp. 4 (1991) 723-729.
24. S. Cuzzocrea, E. Mazzon, G. Costantino, I. Serraino, A. De Sarro, A.P. Caputi, Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury, Cardiovasc. Res. 47 (2000) 537-548.
25. S. Cuzzocrea, E. Mazzon, L. Dugo, I. Serraino, A. Ciccolo, T. Centorrino, A. De Sarro, A.P. Caputi, Protective effects of nacetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat, FASEB J. 15 (2001) 1187-1200.
26. E.L. Conesa, F. Valero, J.C. Nadal, F.J. Fenoy, B. Lopez, B. Arregui, M.G. Salom, N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure, Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R730-R737.
27. M. Matucci-Cerinic, A. Pignone, F. Iannone, T. Lotti, E. Pesciullesi, G. Spillantini, F. Falcini, M. Cagnoni, Clinical correlations of plasma angiotensin converting enzyme activity in systemic sclerosis. A longitudinal study of plasma ACE levels, endothelial injury and lung involvement, Resp. Med. 84 (1990) 283-288.
28. J.H. Warrick, M. Bhalla, S.I. Schabel, R.M. Silver, High resolution computed tomography in early scleroderma lung disease, J. Rhuematol. 18 (1991) 1520-1528.
29. S. Mugnai, M. CiuR, M. Maurizi, D. Bindi, S. Franchi-Micheli, L. Zilletti, Influence of interleukin 1α on superoxide anion, platelet activating factor release and phospholipase A2 activity of naive and sensitized guinea-pig alveolar macrophages, Br. J. Pharmacol. 122 (1997) 1345-1352.
30. N.W. Kooy, J.A. Royall, H. Ischiropoulos, J.S. Beckman, Peroxynitrite-mediated oxidation of dihydrorhodamine-123, Free Radic. Biol. Med. 16 (1994) 149-156.
31. E.P. Garvey, J.A. Oplinger, E.S. Furfine, R.J. Kiff, F. Laszlo, B.J. Whittle, R.G. Knowles, 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo, J. Biol. Chem. 272 (1997) 4959-4963.
32. P. Failli, S. Nistri, S. Quattrone, L. Mazzetti, M. Bigazzi, T. Baniacchi, D. Bani, Relaxin up regulates inducile nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells, FASEB J. (2001), 10.1096/fj.01-0569fje. (Abstract in FASEB J. 2002 16, 252-254).